Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
Randomized, blinded, placebo-controlled trial to demonstrate if pre-exposure prophylaxis
decreases HIV-1 acquisition among HIV-1 uninfected individuals within HIV-1 discordant
couples.
Phase:
Phase 3
Details
Lead Sponsor:
University of Washington
Collaborator:
Bill and Melinda Gates Foundation
Treatments:
Emtricitabine Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Tenofovir